The Global Injection Pen Market size is projected to reach US$ 74.20 billion by 2031, increasing from US$ 42.70 billion in 2023. The market is expected to register a compound annual growth rate (CAGR) of 7.14% from 2023 to 2031. Increasing demand for convenient medication administration, rising prevalence of chronic diseases, and continuous innovation in drug delivery technologies are supporting the expansion of this market.
The Injection Pen Market Growth is driven by the growing adoption of self-injection devices for diabetes, obesity, osteoporosis, growth hormone deficiencies, and other chronic conditions. Injection pens offer controlled dosing, portability, and ease of administration compared with conventional vial-and-syringe methods. Pharmaceutical companies and medical device manufacturers are also investing in disposable, reusable, and connected pen technologies to improve patient experience and support long-term treatment management.
What Is Driving the Injection Pen Market?
The rising prevalence of diabetes is one of the major factors driving demand for injection pens. People with diabetes may require regular insulin administration to manage blood glucose levels. Injection pens provide a convenient alternative to traditional syringes by allowing users to select and administer prescribed doses through a compact device. According to the World Health Organization, approximately 830 million people were living with diabetes worldwide in 2022, highlighting the substantial need for accessible diabetes management solutions.
The growing use of self-administration devices is another important growth driver. Healthcare systems increasingly support home-based treatment for suitable patients, reducing the need for frequent visits to hospitals and clinics. Injection pens can simplify medication administration for individuals who require repeated subcutaneous injections, provided they receive appropriate training and follow product instructions.
Expanding use of injectable medicines for conditions beyond diabetes is also contributing to demand. Treatments for obesity, osteoporosis, autoimmune disorders, growth hormone deficiencies, and certain rare diseases may involve pen-based delivery devices. As pharmaceutical companies introduce new injectable therapies, demand for compatible and reliable delivery platforms is expected to increase.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00002867
How Are Technological Advancements Transforming Injection Pens?
Technological innovation is improving the functionality, safety, and usability of injection pens. Manufacturers are developing devices with improved dose-selection mechanisms, ergonomic designs, clear dose displays, and features that help patients administer medication accurately. These developments are particularly important for older adults and individuals with limited dexterity or visual difficulties.
Smart and connected injection pens are an emerging area of innovation. These devices and compatible attachments can record injection information, including administration time and dosage, and transfer data to mobile applications or digital health platforms. Such features can help patients and healthcare professionals review medication patterns, identify missed doses, and support treatment discussions.
Reusable injection pens are also receiving attention because they allow patients to replace medication cartridges instead of discarding the complete device after each cartridge is used. Manufacturers are exploring durable materials, improved mechanical components, and designs that balance convenience with environmental considerations.
Recent research published in 2025 evaluated the usability of a reusable pen injector among people with diabetes. The study found that most participants considered the device easy to use and learn, including individuals without previous experience with pen injectors. These findings highlight the importance of user-centered design in device development.
What Are the Key Trends in the Injection Pen Market?
- Growing adoption of disposable injection pens
Disposable injection pens are widely used because they are prefilled, convenient, and do not require cartridge replacement. Patients can use the device until the medication is depleted and then dispose of it according to applicable instructions. Their straightforward operation makes them useful for several injectable treatment categories.
- Increasing interest in smart injection pens
Connected devices are gaining attention as healthcare providers seek better visibility into medication administration. Digital dose tracking, reminders, and data-sharing capabilities can support patients who manage complex treatment schedules. Integration with mobile health applications may further strengthen the role of connected injection devices in chronic disease management.
- Expansion of injectable therapies for obesity and chronic conditions
The growing use of injectable medicines for obesity and metabolic disorders is creating additional opportunities for pen manufacturers. Pharmaceutical companies are developing and commercializing injectable treatments that require specialized delivery formats. This is encouraging collaboration between drug developers and device manufacturers to ensure compatibility, dose accuracy, and ease of use.
- Greater focus on patient-friendly device design
Manufacturers are prioritizing features such as smaller needles, comfortable grips, simplified preparation steps, and clear dose indicators. A 2024 usability study of a pen injector for hemophilia treatment reported that most participating patients and caregivers found the device easy or very easy to use. This illustrates the importance of usability in the adoption of self-injection technologies.
What Opportunities Are Emerging for Market Participants?
The expansion of biologic medicines and specialty injectable therapies offers significant opportunities for injection pen manufacturers. Many advanced medicines require carefully designed delivery devices that maintain product stability and provide accurate administration. Device developers can work with pharmaceutical companies to create customized platforms for specific formulations and therapeutic applications.
The growing demand for connected healthcare solutions also creates opportunities for manufacturers of smart injection pens. Partnerships with digital health companies, software developers, and healthcare providers can help expand connected medication-management capabilities. Such solutions may support treatment adherence and provide useful administration information for clinical follow-up.
Emerging markets offer further potential as healthcare infrastructure improves and access to chronic disease diagnosis and treatment expands. Manufacturers can address these opportunities through affordable devices, local partnerships, and patient education initiatives.
Which Companies Are Operating in the Injection Pen Market?
Key companies operating in the injection pen market include:
- Eli Lilly and Company
- Novo Nordisk A/S
- Owen Mumford Ltd.
- Sanofi S.A.
- Merck KGaA
- Haselmeier GmbH
- Gerresheimer AG
- Becton, Dickinson and Company
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
These companies focus on product innovation, pharmaceutical-device integration, manufacturing capabilities, and strategic partnerships. Their activities across injectable medicines and drug delivery technologies contribute to the competitive development of the market.
Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00002867
Future Outlook of the Injection Pen Market
The injection pen market is expected to benefit from continued growth in injectable therapies and increasing demand for convenient self-administration devices. Advances in connected technologies, reusable platforms, and patient-centered designs are likely to influence product development.
The expanding use of injectable treatments for diabetes, obesity, autoimmune disorders, and other chronic conditions will create opportunities for device manufacturers and pharmaceutical companies. Businesses that prioritize reliable dosing, ease of use, product compatibility, and sustainable designs will be better positioned to address changing healthcare requirements.
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
Related Reports:
Infusion Pumps Market Size, Growth & Demand by 2034
Injectable Drug Delivery Market Size, Share, and Growth Analysis by 2031
About Us
The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.
Contact US
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
E-mail : sales@theinsightpartners.com
